Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Key Figures

30.09.2022
Key Figures 30.09.2022
Key Figures 30.09.2022
ABB Completes Accelleron Spin-Off: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
ABB Completes Accelleron Spin-Off


ABB announces that Accelleron Industries AG (formerly ABB Turbocharging), a global leader in high-power turbochargers for mission-critical applications, has been admitted to start trading on SIX

FEMSA receives all regulatory clearances for the public tender offer for Valora
FEMSA receives all regulatory clearances for the public tender offer for Valora
FEMSA receives all regulatory clearances for the public tender offer for Valora
Kuros Biosciences Appoints Chris Fair as Chief Operating Officer
Kuros Biosciences Appoints Chris Fair as Chief Operating Officer
Kuros Biosciences Appoints Chris Fair as Chief Operating Officer
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
Press release: Leonteq is now recognised as a benchmark administrator under the European Benchmarks Regulation
Press release: Leonteq is now recognised as a benchmark administrator under the European Benchmarks Regulation
Press release: Leonteq is now recognised as a benchmark administrator under the European Benchmarks Regulation
Leclanché concludes its 2022 Annual General Meeting
Leclanché concludes its 2022 Annual General Meeting
Leclanché concludes its 2022 Annual General Meeting
Corrigendum: Cembra to acquire Byjuno to create a leading provider of invoice payment solutions in Switzerland
Corrigendum: Cembra to acquire Byjuno to create a leading provider of invoice payment solutions in Switzerland
Corrigendum: Cembra to acquire Byjuno to create a leading provider of invoice payment solutions in Switzerland
ABB to Sell Remaining Stake in Hitachi Energy to Hitachi: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23978/ABB_logo.svg.png
ABB to Sell Remaining Stake in Hitachi Energy to Hitachi


ABB has reached an agreement to divest to Hitachi, Ltd. (Hitachi) its remaining 19.9 percent equity stake in the Hitachi Energy joint venture that was formed from ABB’s Power Grids business in

Cembra to acquire Byjuno to create a leading provider of invoice payment solutions in Switzerland
Cembra to acquire Byjuno to create a leading provider of invoice payment solutions in Switzerland
Cembra to acquire Byjuno to create a leading provider of invoice payment solutions in Switzerland
FEMSA publishes the provisional end result of the public tender offer for Valora – participation rate of 96.87%
FEMSA publishes the provisional end result of the public tender offer for Valora – participation rate of 96.87%
FEMSA publishes the provisional end result of the public tender offer for Valora – participation rate of 96.87%
Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety
Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety
Kinarus Therapeutics Announces Discontinuation of the Phase 2 KINETIC Study of KIN001 in Hospitalized COVID-19 Patients Following a Prespecified Interim Analysis of Efficacy and Safety
UBS Advisor Roger Vierra Named to the 2022 PLANADVISER Top Retirement Plan Advisers List: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23976/300px-UBS_Logo_SVG.svg.png
UBS Advisor Roger Vierra Named to the 2022 PLANADVISER Top Retirement Plan Advisers List


UBS Wealth Management USA announced today that Roger Vierra, a Financial Advisor in the firm’s Rockland, MA office, has been named to the 2022 PLANADVISER Top Retirement Plan Advisers list.



"It

Change in the Board of Directors at the CREALOGIX Group
Change in the Board of Directors at the CREALOGIX Group
Change in the Board of Directors at the CREALOGIX Group
Top-up bitcoin wallets available at k kiosk, Press & Books and avec
Top-up bitcoin wallets available at k kiosk, Press & Books and avec
Top-up bitcoin wallets available at k kiosk, Press & Books and avec
Leclanché announces delay in the publication of its 2022 interim results
Leclanché announces delay in the publication of its 2022 interim results
Leclanché announces delay in the publication of its 2022 interim results
Four UBS advisors in the Greater New England Wealth Management Market named to Forbes/SHOOK Top Next-Gen Wealth Advisors Best-In-State list: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23976/300px-UBS_Logo_SVG.svg.png
Four UBS advisors in the Greater New England Wealth Management Market named to Forbes/SHOOK Top Next-Gen Wealth Advisors Best-In-State list


UBS Wealth Management USA is proud to announce that four Financial Advisors in the firm’s Greater New England Market, have been named to the Forbes/SHOOK Top Next-Gen Wealth Advisors Best-In-State

Dufry wins new duty-paid contract at Chongqing International Airport in China
Dufry wins new duty-paid contract at Chongqing International Airport in China
Dufry wins new duty-paid contract at Chongqing International Airport in China
mobilezone admitted to sustainability index of the Swiss stock exchange
mobilezone admitted to sustainability index of the Swiss stock exchange
mobilezone admitted to sustainability index of the Swiss stock exchange
Tavneos® erhält Swissmedic-Zulassung für die Behandlung ANCA-assoziierter Vaskulitis: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Tavneos® erhält Swissmedic-Zulassung für die Behandlung ANCA-assoziierter Vaskulitis


Vifor Fresenius Medical Care Renal Pharma (VFMCRP) hat heute die Zulassung von Tavneos® durch die Schweizerische Zulassungs- und Aufsichtsbehörde für Arzneimittel und Medizinprodukte Swissmedic

Cicor announces exercise of reopening option for the issuance of additional mandatory convertible bonds and of option to sell those bonds to One Equity Partners
Cicor announces exercise of reopening option for the issuance of additional mandatory convertible bonds and of option to sell those bonds to One Equity Partners
Cicor announces exercise of reopening option for the issuance of additional mandatory convertible bonds and of option to sell those bonds to One Equity Partners
MSCI upgrades Baloise’s sustainability rating once again
MSCI upgrades Baloise’s sustainability rating once again
MSCI upgrades Baloise’s sustainability rating once again
HIAG Capital Market Day 2022 – In-depth insight into business model
and functional areas
HIAG Capital Market Day 2022 – In-depth insight into business model and functional areas
HIAG Capital Market Day 2022 – In-depth insight into business model and functional areas
Cicor continues to grow and doubles its production capacity for high quality electronics in Vietnam
Cicor continues to grow and doubles its production capacity for high quality electronics in Vietnam
Cicor continues to grow and doubles its production capacity for high quality electronics in Vietnam
Baloise Art Prize: Third and fourth gift to Hamburger Bahnhof in Berlin
Baloise Art Prize: Third and fourth gift to Hamburger Bahnhof in Berlin
Baloise Art Prize: Third and fourth gift to Hamburger Bahnhof in Berlin